Andere Sprachen Aptevo Therapeutics Inc.

Aktien

A403XC

US03835L3069

APVO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
0.96 ^USD	+35.08%		+40.64%	-87.95%

11.04.	US-Aktienmärkte schließen nach den Daten zur Erzeugerpreisinflation im März uneinheitlich	MT
11.04.	Top-Mittagskursrückgänge	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aptevo Therapeutics : 2024 Shareholder Letter	26.04.
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering	16.04.
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering	12.04.
US Equity Markets Close Mixed After March Producer Price Inflation Data	11.04.
Top Midday Decliners	11.04.
Top Premarket Decliners	11.04.
Aptevo Therapeutics Inc. Provides Pipeline Update	10.04.
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07.03.
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07.03.
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update	06.03.
Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05.03.
Alligator Bioscience AB reports full year financial results for 2023 and for Q4 2023 and provides a business update	08.02.
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update	15.11.
Aptevo Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Certain Warrants of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03.11.
Certain Stock Options of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03.11.
Certain Common Stock of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 3-NOV-2023.	03.11.
Aptevo to Present at Bio-Europe Conference	02.11.
Aptevo Therapeutics : 28 August 2023 Investor Presentation	28.08.23
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update	11.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aptevo Therapeutics Inc.

Aktien

A403XC

US03835L3069

APVO

Andere Sprachen

Filter